Co-trimoxazole in prevention of purulent exacerbations of chronic bronchitis.
D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D004338:Drug Combinations; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D013492:Suppuration / Q000517:prevention & control*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole